216 related articles for article (PubMed ID: 10645841)
21. Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: recommendations for management.
Rosenberg MH; Deerfield LJ; Baruch EM
Am J Drug Alcohol Abuse; 2003 May; 29(2):487-96. PubMed ID: 12765217
[TBL] [Abstract][Full Text] [Related]
22. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G
Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048
[TBL] [Abstract][Full Text] [Related]
23. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L
Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
[TBL] [Abstract][Full Text] [Related]
25. Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known.
van Noorden MS; van Dongen LC; Zitman FG; Vergouwen TA
Gen Hosp Psychiatry; 2009; 31(4):394-6. PubMed ID: 19555805
[TBL] [Abstract][Full Text] [Related]
26. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal.
Miotto K; Darakjian J; Basch J; Murray S; Zogg J; Rawson R
Am J Addict; 2001; 10(3):232-41. PubMed ID: 11579621
[TBL] [Abstract][Full Text] [Related]
27. Gamma hydroxybutyric acid (GHB) intoxication.
Mason PE; Kerns WP
Acad Emerg Med; 2002 Jul; 9(7):730-9. PubMed ID: 12093716
[TBL] [Abstract][Full Text] [Related]
28. Pentobarbital for severe gamma-butyrolactone withdrawal.
Sivilotti ML; Burns MJ; Aaron CK; Greenberg MJ
Ann Emerg Med; 2001 Dec; 38(6):660-5. PubMed ID: 11719746
[TBL] [Abstract][Full Text] [Related]
29. Inpatient management of gamma-hydroxybutyrate withdrawal.
Cappetta M; Murnion BP
Australas Psychiatry; 2019 Jun; 27(3):284-287. PubMed ID: 30652947
[TBL] [Abstract][Full Text] [Related]
30. Treatment of Gamma Hydroxybutyrate Withdrawal in a Pregnant Female: A Case Report.
Joyce S; Lea S; Woolner M; Leddy A
J Addict Med; 2024 May-Jun 01; 18(3):342-344. PubMed ID: 38345233
[TBL] [Abstract][Full Text] [Related]
31. The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms.
J Toxicol Clin Toxicol; 2003; 41(2):131-5. PubMed ID: 12733850
[TBL] [Abstract][Full Text] [Related]
32. [Withdrawal syndrome following chronic use of gamma-hydroxybutyric acid (GHB)].
Moitroux A; Kestens C
Rev Med Liege; 2023 Jul; 78(7-8):451-455. PubMed ID: 37560960
[TBL] [Abstract][Full Text] [Related]
33. Gamma-hydroxybutyrate abuse: pharmacology and poisoning and withdrawal management.
Marinelli E; Beck R; Malvasi A; Lo Faro AF; Zaami S
Arh Hig Rada Toksikol; 2020 Mar; 71(1):19-26. PubMed ID: 32597141
[TBL] [Abstract][Full Text] [Related]
34. Within-patient variability in clinical presentation of gamma-hydroxybutyrate withdrawal: a case report.
Glasper A; McDonough M; Bearn J
Eur Addict Res; 2005; 11(3):152-4. PubMed ID: 15990433
[TBL] [Abstract][Full Text] [Related]
35. Gamma-Hydroxybutyrate (GHB) Withdrawal in a Patient with Polysubstance Use.
Bernstein A
J Psychoactive Drugs; 2021; 53(4):299-301. PubMed ID: 33357048
[TBL] [Abstract][Full Text] [Related]
36. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.
Leone MA; Vigna-Taglianti F; Avanzi G; Brambilla R; Faggiano F
Cochrane Database Syst Rev; 2010 Feb; (2):CD006266. PubMed ID: 20166080
[TBL] [Abstract][Full Text] [Related]
37. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4654-63. PubMed ID: 26698265
[TBL] [Abstract][Full Text] [Related]
38. Gamma-hydroxybutyrate reduces both withdrawal syndrome and hypercortisolism in severe abstinent alcoholics: an open study vs. diazepam.
Nava F; Premi S; Manzato E; Campagnola W; Lucchini A; Gessa GL
Am J Drug Alcohol Abuse; 2007; 33(3):379-92. PubMed ID: 17613965
[TBL] [Abstract][Full Text] [Related]
39. [Gamma-hydroxybutyrate--an endogenous substance and an intoxicant].
Hovda KE; Liberg JP; Nordby G; Jacobsen D
Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4390-3. PubMed ID: 9889613
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of gamma-hydroxybutyrate withdrawal].
Strand NAW; Petersen TS; Nielsen LM; Boegevig S
Ugeskr Laeger; 2017 Dec; 179(50):. PubMed ID: 29260701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
